Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells ; volume:12 ; number:1 ; day:6 ; month:2 ; year:2021 ; pages:1-20 ; date:12.2021
Cancer nanotechnology ; 12, Heft 1 (6.2.2021), 1-20, 12.2021
- Urheber
-
Poonaki, Elham
Ariakia, Fatemeh
Jalili-Nik, Mohammad
Shafiee Ardestani, Mehdi
Tondro, Gholamhossein
Samini, Fariborz
Ghasemi, Sepideh
Sahab-Negah, Sajad
Gorji, Ali
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12645-021-00078-8
- URN
-
urn:nbn:de:101:1-2021042818450267003303
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Poonaki, Elham
- Ariakia, Fatemeh
- Jalili-Nik, Mohammad
- Shafiee Ardestani, Mehdi
- Tondro, Gholamhossein
- Samini, Fariborz
- Ghasemi, Sepideh
- Sahab-Negah, Sajad
- Gorji, Ali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Aptamer-labeled PLGA nanoparticles for targeting cancer cells